Ellington Management Group’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-33,500
Closed -$482K 396
2020
Q1
$482K Buy
+33,500
New +$962K 0.11% 251
2019
Q1
Sell
-187,905
Closed -$3.22M 690
2018
Q4
$3.22M Buy
+187,905
New +$4.55M 0.98% 14
2018
Q2
Sell
-60,100
Closed -$1.46M 847
2018
Q1
$1.46M Buy
+60,100
New +$1.2M 0.1% 112
2017
Q1
Sell
-10,000
Closed -$148K 871
2016
Q4
$148K Buy
+10,000
New +$179K 0.02% 475
2015
Q3
Sell
-9,808
Closed -$568K 896
2015
Q2
$568K Buy
+9,808
New +$501K 0.14% 206
2014
Q1
Sell
-4,900
Closed -$206K 767
2013
Q4
$206K Sell
4,900
-4,500
-48% -$196K 0.07% 454
2013
Q3
$387K Buy
9,400
+3,000
+47% +$125K 0.07% 415
2013
Q2
$295K Buy
+6,400
New +$287K 0.06% 515

Other funds holding THC

Ellington Management Group's THC Position: Q2 2020 in Review

Ellington Management Group sold out of Tenet Healthcare (THC) in Q2 2020, closing a stake of 33,500 shares — an estimated $482K sold.

Ellington Management Group first reported a position in THC in Q2 2013 and held it in 8 quarters. The position peaked at $3.22M in Q4 2018. 239 funds tracked by Wall St. Rank hold THC as of Q2 2020.

  • Ellington Management Group reported no remaining Tenet Healthcare position as of Q2 2020 after selling out during the quarter.
  • Ellington Management Group sold 33,500 Tenet Healthcare shares in Q2 2020, an estimated $482K.
  • Ellington Management Group first reported a position in Tenet Healthcare in Q2 2013 and held it in 8 quarters.
  • Ellington Management Group's Tenet Healthcare position peaked at $3.22M in Q4 2018.
  • 239 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2020.

Based on Ellington Management Group's 13F filing for Q2 2020, filed 17 Aug 2020.